Growth Metrics

Volitionrx (VNRX) Cash from Investing Activities (QoQ) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -4,146.85%
Mar 31, 2025 99.09%
Dec 31, 2024 -44.70%
Sep 30, 2024 14.78%
Jun 30, 2024 -103.59%
Mar 31, 2024 74.47%
Dec 31, 2023 -13.07%
Sep 30, 2023 9.41%
Jun 30, 2023 -50.25%
Mar 31, 2023 65.34%
Dec 31, 2022 -77.81%
Sep 30, 2022 39.87%
Jun 30, 2022 -334.26%
Mar 31, 2022 3.05%
Dec 31, 2021 9.33%
Sep 30, 2021 35.32%
Jun 30, 2021 54.70%
Mar 31, 2021 54.57%
Dec 31, 2020 -7,215.64%
Sep 30, 2020 105.61%
Jun 30, 2020 19.36%
Mar 31, 2020 -117.90%
Dec 31, 2019 -23.72%
Sep 30, 2019 1.65%
Jun 30, 2019 -11.26%
Mar 31, 2019 5.21%
Dec 31, 2018 -103.81%
Sep 30, 2018 10.53%
Jun 30, 2018 -6.92%
Mar 31, 2018 28.63%
Dec 31, 2017 19.32%
Sep 30, 2017 70.74%
Jun 30, 2017 58.85%
Mar 31, 2017 -168.65%
Dec 31, 2016 -1,447.00%
Dec 31, 2015 -64.99%
Sep 30, 2015 87.16%
Jun 30, 2015 40.05%
Mar 31, 2015 -1,261.98%
Dec 31, 2014 97.86%
Sep 30, 2014 -777.28%
Jun 30, 2014 -58.32%
Mar 31, 2014 -1,806,600.00%
Dec 31, 2013 -200.00%
Mar 31, 2013 96.26%
Dec 31, 2012 -4,099.78%
Sep 30, 2012 98.63%
Jun 30, 2012 11.83%
Mar 31, 2012 -265.57%
Dec 31, 2011 48.98%
Sep 30, 2011 -375.32%